Articles dans des revues avec comité de lecture (396)

  1. 265. Rosa, D. D., Ismael, G., Dal Lago, L., & Awada, A. (2008). Molecular-targeted therapies: lessons from years of clinical development. Cancer treatment reviews, 34(1), 61-80. doi:10.1016/j.ctrv.2007.07.019
  2. 266. Zielinski, C. C., Awada, A., Cameron, D. A., Cufer, T., Martin, M., & Aapro, M. (2008). The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients. European journal of cancer, 44(3), 353-365. doi:10.1016/j.ejca.2007.11.024
  3. 267. Awada, A., Cardoso, F., Fontaine, C., Dirix, L. Y., De Greve, J., Sotiriou, C., Steinseifer, J., Wouters, C., Tanaka, C., Zoellner, U., Tang, P., & Piccart-Gebhart, M. (2008). The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokinetics. European journal of cancer, 44(1), 84-91. doi:10.1016/j.ejca.2007.10.003
  4. 268. Dequanter, D., Lothaire, P., Lemort, M., Canizares, P. A. C., Lalami, Y., & Awada, A. (2008). Intérêt du scanner thoracique dans le bilan initial et le suivi des patients traités pour un cancer des voies aérodigestives supérieures. Revue de laryngologie, d'otologie et de rhinologie, 129(4-5), 273-276.
  5. 269. Andersson, M., Awada, A., Barrett-Lee, P., Ellis, P., Hupperets, P., Jackisch, C., Kubista, E., Luck, H. J., Monerat, C., Nitz, U., & Untch, M. (2008). European oncologists preferences for the management of breast cancer: case presentations and expert commentary. Breast, 17(2), 1-11.
  6. 270. Klastersky, J., Awada, A., & Paesmans, M. (2008). Traitement de la neutropénie fébrile basé sur la prédiction du risque de complications. Oncologie, 2(3), 89-92.
  7. 271. Larsimont, D., Durbecq, V., Awada, A., & Di Leo, A. (2008). HER2 and topoisomerase IIa: Useful clinical markers in breast cancer. Bulletin du cancer, 95(3), 344-351.
  8. 272. Van Nooten, F., Dewilde, S., Marbaix, S., Van Belle, S., Sautois, B., Awada, A., Focan, C., Verhoeven, D., & Gil, T. (2008). An economic approach of metastatic renal cell carcinoma (mRCC) in Belgium. Acta Clinica Belgica (English ed. Printed).
  9. 273. Wildiers, H., Sonet, A., Neefs, A., Elaheebux, M., Borghuys, W., Awada, A., & Dirix, L. (2008). Consensus text on the utilization of dexrazonane (Savene®) in anthracycline extravasation. Belgian journal of medical oncology, 2(2).
  10. 274. Vos, B., Awada, A., & Hendlisz, A. (2008). Primary small-cell carcinoma of the pancreas: An extensive review of the literature with emphasis on therapy and prognosis. Cancer Therapy, 6.
  11. 275. Vos, B., Gallez, J., Debroux, S., Roland, S., Verhest, A., Van Houtte, P., Awada, A., & Hendlisz, A. (2008). Concomitant chemo-radiotherapy as standard therapy in limited-stage small-cell oesophageal cancer: a summary of 3 clinical cases and review of the literature. Acta gastro-enterologica Belgica (Ed. multilingue), 71(3), 325-329.
  12. 276. Awada, A., & Paridaens, R. (2008). The role of Caelyx in metastatic breast cancer. Belgian journal of medical oncology, 1(2).

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37
    38 39 Suivant >>